<DOC>
	<DOC>NCT00695084</DOC>
	<brief_summary>This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.</brief_summary>
	<brief_title>Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)</brief_title>
	<detailed_description>Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Chronic upper extremity motor deficit due to multiple sclerosis Relapse within 3 months of planned enrollment.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>multiple sclerosis</keyword>
</DOC>